Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol.

IF 2.6 3区 医学 Q2 RESPIRATORY SYSTEM BMC Pulmonary Medicine Pub Date : 2024-10-10 DOI:10.1186/s12890-024-03329-7
Harriett Myers, Bartolomeu Chongo, Jerry S Zifodya, Isabel Zacaria, Estevão Machava, André Simango, Gustavo Amorim, Elzier Mavume-Mangunyane, Rogério Chiau, Kathryn T Kampa, Tavares Madede, Mohsin Sidat, Troy D Moon
{"title":"Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol.","authors":"Harriett Myers, Bartolomeu Chongo, Jerry S Zifodya, Isabel Zacaria, Estevão Machava, André Simango, Gustavo Amorim, Elzier Mavume-Mangunyane, Rogério Chiau, Kathryn T Kampa, Tavares Madede, Mohsin Sidat, Troy D Moon","doi":"10.1186/s12890-024-03329-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite receiving adequate treatment, many tuberculosis (TB) survivors are left with post-tuberculosis complications, possibly due to lung tissue damage incurred during the active period of the disease. Current TB programs worldwide deliver quality care throughout the course of active TB treatment, yet often fail to provide organized follow-up once treatment ends. Post-tuberculosis lung disease (PTLD) is a prominent, yet underrecognized cause of chronic lung disease, managed similarly to chronic respiratory diseases with pharmacotherapy and/or personalized pulmonary rehabilitation interventions. Basic pulmonary rehabilitation packages for people finishing TB treatment are still lacking in low- and middle-income countries (LMICs). We offer a study protocol to evaluate the implementation of spirometry and symptom screening for PTLD among people who have completed TB treatment in a rural district in Mozambique.</p><p><strong>Methods: </strong>The overall objective of this study is to evaluate the introduction of a new screening program that utilizes symptom screening and spirometry for diagnosing PTLD among adolescents and adults that have completed TB treatment. This research protocol consists of three complementary components: 1) assessing the prevalence of PTLD among patients enrolled in the National TB Control Program (NTCP) at Carmelo Hospital (CHC) in Chókwè District, Mozambique; 2) evaluating anticipated implementation outcomes through the identification of the site-, provider-, and individual-level determinants that either facilitate or hinder the successful adoption, implementation, and maintenance of the spirometry screening program, and 3) evaluating the real-time implementation outcomes/processes in order to provide practical evidence-based key indicators of successful implementation of the spirometry screening program.</p><p><strong>Discussion: </strong>Providing well-organized, evidence-based care for individuals with a history of TB who are experiencing symptoms of PTLD can relieve chronic respiratory issues, enhance quality of life, and potentially lower the risk of further pulmonary infections, including recurrent TB. However, there is a significant gap in the literature regarding the implementation of best practices of HIV and TB health services delivery. Addressing this gap could assist Mozambique in improving diagnosis, treatment, and continuity of care for people formerly living with TB. The insights from this study will help decision-makers improve spirometry screening coverage, enhance intervention effectiveness, and translate our findings to evidence-based programming.</p><p><strong>Trial registration: </strong>ISRCTN92021748 retrospectively registered.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"24 1","pages":"502"},"PeriodicalIF":2.6000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11465890/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pulmonary Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12890-024-03329-7","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Despite receiving adequate treatment, many tuberculosis (TB) survivors are left with post-tuberculosis complications, possibly due to lung tissue damage incurred during the active period of the disease. Current TB programs worldwide deliver quality care throughout the course of active TB treatment, yet often fail to provide organized follow-up once treatment ends. Post-tuberculosis lung disease (PTLD) is a prominent, yet underrecognized cause of chronic lung disease, managed similarly to chronic respiratory diseases with pharmacotherapy and/or personalized pulmonary rehabilitation interventions. Basic pulmonary rehabilitation packages for people finishing TB treatment are still lacking in low- and middle-income countries (LMICs). We offer a study protocol to evaluate the implementation of spirometry and symptom screening for PTLD among people who have completed TB treatment in a rural district in Mozambique.

Methods: The overall objective of this study is to evaluate the introduction of a new screening program that utilizes symptom screening and spirometry for diagnosing PTLD among adolescents and adults that have completed TB treatment. This research protocol consists of three complementary components: 1) assessing the prevalence of PTLD among patients enrolled in the National TB Control Program (NTCP) at Carmelo Hospital (CHC) in Chókwè District, Mozambique; 2) evaluating anticipated implementation outcomes through the identification of the site-, provider-, and individual-level determinants that either facilitate or hinder the successful adoption, implementation, and maintenance of the spirometry screening program, and 3) evaluating the real-time implementation outcomes/processes in order to provide practical evidence-based key indicators of successful implementation of the spirometry screening program.

Discussion: Providing well-organized, evidence-based care for individuals with a history of TB who are experiencing symptoms of PTLD can relieve chronic respiratory issues, enhance quality of life, and potentially lower the risk of further pulmonary infections, including recurrent TB. However, there is a significant gap in the literature regarding the implementation of best practices of HIV and TB health services delivery. Addressing this gap could assist Mozambique in improving diagnosis, treatment, and continuity of care for people formerly living with TB. The insights from this study will help decision-makers improve spirometry screening coverage, enhance intervention effectiveness, and translate our findings to evidence-based programming.

Trial registration: ISRCTN92021748 retrospectively registered.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在莫桑比克 Chókwè 区 Carmelo 医院国家结核病控制项目的青少年和成人中实施肺活量测定筛查肺结核后肺病 (PTLD):第三类效果-实施混合研究方案。
背景:尽管接受了适当的治疗,但许多结核病(TB)幸存者仍会出现结核病后并发症,这可能是由于肺组织在疾病活动期受到损伤所致。目前全球的结核病项目在结核病活动期的整个治疗过程中提供高质量的护理,但在治疗结束后往往无法提供有组织的后续治疗。结核病后肺部疾病(PTLD)是慢性肺部疾病的一个突出病因,但却未得到充分认识,其治疗方法与慢性呼吸系统疾病类似,都是通过药物治疗和/或个性化肺康复干预来实现的。在中低收入国家(LMICs),针对肺结核治疗后患者的基本肺康复治疗方案仍然缺乏。我们提供了一份研究方案,以评估莫桑比克农村地区肺结核治疗结束者肺活量测定和 PTLD 症状筛查的实施情况:本研究的总体目标是评估一项新筛查计划的引入情况,该计划利用症状筛查和肺活量测定来诊断已完成肺结核治疗的青少年和成人中的 PTLD。该研究方案由三个互补部分组成:1)评估莫桑比克 Chókwè 区 Carmelo 医院(CHC)参加国家结核病控制计划(NTCP)的患者中 PTLD 的患病率;2)通过确定促进或阻碍成功采用、实施和维持肺活量筛查项目的场所、提供者和个人层面的决定因素,评估预期的实施结果;以及 3)评估实时实施结果/过程,以便为成功实施肺活量筛查项目提供实用的循证关键指标。讨论:为有肺结核病史且出现 PTLD 症状的患者提供有序、循证的治疗,可以缓解慢性呼吸系统问题,提高生活质量,并有可能降低进一步肺部感染(包括复发性肺结核)的风险。然而,在提供艾滋病毒和结核病医疗服务的最佳实践方面,文献资料还存在很大差距。弥补这一差距可以帮助莫桑比克改善对肺结核患者的诊断、治疗和持续护理。本研究的见解将帮助决策者提高肺活量筛查的覆盖率,增强干预效果,并将我们的发现转化为循证计划:ISRCTN92021748 回顾性注册。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Pulmonary Medicine
BMC Pulmonary Medicine RESPIRATORY SYSTEM-
CiteScore
4.40
自引率
3.20%
发文量
423
审稿时长
6-12 weeks
期刊介绍: BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
期刊最新文献
Predicting solitary pulmonary lesions in breast cancer patients using 18fluorodeoxyglucose-positron emission tomography/computed tomography combined with clinicopathological characteristics. Assessment of novel cardiovascular biomarkers in chronic obstructive pulmonary disease. Comparison of efficacy and safety of neoadjuvant immunochemotherapy in young and elderly patients with IIA-IIIB non-small-cell lung cancer in real-world practice. Development of a predictive nomogram for early identification of pulmonary embolism in hospitalized patients: a retrospective cohort study. A nomogram for predicting lymphovascular invasion in lung adenocarcinoma: a retrospective study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1